C3a Antibody (Monoclonal)

A murine monoclonal antibody to the human C3a domain of C3.


Product Specifications

Citations3
Clonality

Monoclonal

Immnogen

Purified human protein.

Applications

See citations and technical data sheet for application info.

Concentration1.0-1.2 mg/mL
ConjugateUnconjugated
Cross Reactivity

Human, Baboon, Cynomologus macaque, Rhesus macaque, Pig

Ordering Information

For Research Use Only in the United States. Not for use in diagnostic procedures.
Catalog NumberA203
Catalog Number (CE)N/A
Size100 µl
Price (USD)$365.00
Price (EURO)330,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

A murine monoclonal antibody to the human C3a domain of C3.

Size

100 µl

Concentration1.0-1.2 mg/mL
ApplicationsSee citations and technical data sheet for application info.
FormLiquid. Borate Buffered Saline (pH 8.4 ± 0.2), with ≤ 0.1% Sodium Azide.
ClonalityMonoclonal
Immunogen

Purified human protein.

ConjugateUnconjugated
Cross ReactivityHuman, Baboon, Cynomologus macaque, Rhesus macaque, Pig
Isotype

IgG1k

Purity

≥ 95% by SDS PAGE

SourceMouse
Specificity

This monoclonal antibody was raised against purified human C3. It is specific for an antigen expressed on the C3a domain of C3 and therefore reactive to C3 and C3a.

Storage

Short term (30 days) 4˚C. Long term at or below –20˚C.

Background

The human complement component, C3, consists of two disulfide-bonded subunits (Alpha – 115,000 kD and Beta – 75,000 kD). The concentration of C3 in serum is approximately 1.25 + 0.52 mg/ml. Under normal conditions, activation of either the Classical, Lectin or Alternative Complement Pathways produces C3 convertase which cleaves C3 into two fragments – C3a, an anaphylatoxin, and C3b. Quidel’s monoclonal antibodies to complement antigens were prepared using standard techniques. They are purified from mouse ascites fluid via Protein A affinity chromatography. Quidel’s Anti-Human C3a monoclonal antibody was raised against highly pure human C3 protein.

Citations

TitleYearApplicationsSample SpeciesSampleSample Details

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

2013FCHuman

HUVEC Cells

aHUS

Structural transitions of complement component C3 and its activation products

2006Electron MicroscopyHuman

Purified protein

N/A

Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans.

1998Complement Activation AssayHuman

Polymorphonuclear Cells

Cryptococcus neoformans